Melatonin as a potential inhibitory agent in head and neck cancer

Chia Ming Yeh, Shih Chi Su, Chiao Wen Lin, Wei En Yang, Ming Hsien Chien, Russel J. Reiter, Shun Fa Yang

研究成果: 雜誌貢獻回顧型文獻

18 引文 斯高帕斯(Scopus)

摘要

Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of melatonin on hormone-dependent tumors. In this review, we highlight recent advances in understanding the effects of melatonin on the development of head and neck cancers, including molecular mechanisms identified through experimental and clinical observations. Because melatonin exerts a wide range of effects, melatonin may influence many mechanisms that influence the development of cancer. These include cell proliferation, apoptosis, angiogenesis, extracellular matrix remodeling through matrix metalloproteinases, and genetic polymorphism. Thus, the evidence discussed in this article will serve as a basis for basic and clinical research to promote the use of melatonin for understanding and controlling the development of head and neck cancers.

原文英語
頁(從 - 到)90545-90556
頁數12
期刊Oncotarget
8
發行號52
DOIs
出版狀態已發佈 - 2017

ASJC Scopus subject areas

  • Oncology

指紋 深入研究「Melatonin as a potential inhibitory agent in head and neck cancer」主題。共同形成了獨特的指紋。

  • 引用此

    Yeh, C. M., Su, S. C., Lin, C. W., Yang, W. E., Chien, M. H., Reiter, R. J., & Yang, S. F. (2017). Melatonin as a potential inhibitory agent in head and neck cancer. Oncotarget, 8(52), 90545-90556. https://doi.org/10.18632/oncotarget.20079